Results 251 to 260 of about 45,427 (283)
Some of the next articles are maybe not open access.

CMT

2009
Nils Peters   +199 more
openaire   +1 more source

CMT-COVID Survey

Clinical Medical Case Reports and Reviews, 2022
openaire   +1 more source

CMT 73 26021

2021
Ranasinghe, Gerard   +2 more
openaire   +1 more source

CMT

Neurology Today, 2003
openaire   +1 more source

CMT-3. CollaGenex.

Current opinion in investigational drugs (London, England : 2000), 2004
CMT-3 is an orally active matrix metalloprotease inhibitor, and one of a series of inhibitors of multiple proteases and cytokines, under development by CollaGenex. The compound is currently undergoing phase II trials for the potential treatment of cancer, in particular metastatic cancer and HIV-related Kaposi's sarcoma.
openaire   +1 more source

CMT

2011
openaire   +1 more source

CMT

2006
openaire   +1 more source

Microstructure and mechanical properties of 6061/7N01 CMT+P joints

Journal of Materials Processing Technology, 2019
Shengsun Hu, Junqi Shen
exaly  

A Review of Genetic Counseling for Charcot Marie Tooth Disease (CMT)

Journal of Genetic Counseling, 2013
Seema Panchal   +2 more
exaly  

Home - About - Disclaimer - Privacy